Your session is about to expire
← Back to Search
NA
Experimental: Arm 1 (Aerobic Exercise) for Prostate Cancer (CHAMP Trial)
N/A
Waitlist Available
Led By Stacey A Kenfield, ScD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 2 years
Awards & highlights
CHAMP Trial Summary
This study is evaluating whether exercise is safe and feasible for men with metastatic castration resistant prostate cancer.
Eligible Conditions
- Prostate Cancer
CHAMP Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 2 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Adherence at 70% or more of the completed exercise sessions.
Attendance at 70% or more of exercise sessions.
Median sessional tolerance
+2 moreSecondary outcome measures
Change in FACT-General (FACT-G) social/family wellbeing domain.
Change in Scores on the Brief-Pain Inventory Short Form (BPI-SF)
Mental Depression
+11 moreOther outcome measures
Median Overall Survival (OS)
Median Progression-free Survival (PFS)
Median time to first occurrence of Symptomatic Skeletal-related Events (SSE)
+1 moreCHAMP Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Experimental: Arm 2 (Resist. Exercise)Experimental Treatment1 Intervention
Arm 2 will engage in a periodized program consisting of 3 resistance exercise sessions per week comprised of various loads and volumes. A physical assessment, physical function and strengths tests, and questionnaires will be completed at baseline and 3 months.
Group II: Experimental: Arm 1 (Aerobic Exercise)Experimental Treatment1 Intervention
Arm 1 will engage in a periodized program consisting of 3 aerobic exercise sessions per week comprised of two high-intensity interval training workouts and 1 continuous vigorous intensity workout. A physical assessment, physical function and strengths tests, and questionnaires will be completed at baseline and 3 months.
Group III: No Intervention: Arm 3 (Control)Active Control1 Intervention
Arm 3 will follow their usual exercise and lifestyle routine. A physical assessment, physical function and strengths tests, and questionnaires will be completed at baseline and 3 months.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Experimental: Arm 1 (Aerobic Exercise)
2016
N/A
~30
Experimental: Arm 2 (Resist. Exercise)
2016
N/A
~30
Find a Location
Who is running the clinical trial?
University of California, San FranciscoLead Sponsor
2,505 Previous Clinical Trials
15,237,527 Total Patients Enrolled
51 Trials studying Prostate Cancer
17,005 Patients Enrolled for Prostate Cancer
National Cancer Institute (NCI)NIH
13,664 Previous Clinical Trials
40,925,977 Total Patients Enrolled
560 Trials studying Prostate Cancer
507,067 Patients Enrolled for Prostate Cancer
Stacey A Kenfield, ScDPrincipal InvestigatorUniversity of California, San Francisco
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger